Q3 2025 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2025-11-13 · accession 0001104659-25-111225
$322.9M
Reported value
39
Positions
2025-09-30
Period end
The Brief · Bruce & Co., Inc. · Q3 2025
AI · grounded in 13F
Bruce & Co., Inc. established a new position in Abbvie ABBV valued at $29.5M. The fund also initiated new stakes in Allstate ALL for $26.9M and Nextera Energy for $23.8M. Additional new positions include Uhaul B UHAL/B at $23M and AerCap Holdings AER at $22.2M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00287Y109 | ABBV | Abbvie | $29.5M | 9.14% | 127,500 | Common | SOLE |
| 020002101 | ALL | Allstate | $26.9M | 8.34% | 125,500 | Common | SOLE |
| 302571104 | — | Nextera Energy | $23.8M | 7.36% | 315,000 | Common | SOLE |
| 023586506 | UHAL/B | Uhaul B | $23.0M | 7.12% | 452,000 | Common | SOLE |
| N00985106 | AER | AerCap Holdings | $22.2M | 6.88% | 183,500 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $19.3M | 5.97% | 155,816 | Common | SOLE |
| 002824100 | ABT | Abbott | $17.9M | 5.55% | 133,800 | Common | SOLE |
| 589331107 | — | Merck | $16.2M | 5.01% | 192,800 | Common | SOLE |
| 98389B100 | XEL | XCEL Energy | $15.7M | 4.86% | 194,500 | Common | SOLE |
| 00206R102 | T | AT & T | $14.8M | 4.57% | 523,000 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $13.2M | 4.08% | 343,423 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $11.4M | 3.54% | 156,000 | Common | SOLE |
| 037833100 | AAPL | Apple | $9.9M | 3.07% | 38,900 | Common | SOLE |
| 651639106 | NEM | Newmont | $8.4M | 2.61% | 100,000 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.6M | 2.36% | 201,500 | Common | SOLE |
| 717081103 | PFE | Pfizer | $6.9M | 2.15% | 271,900 | Common | SOLE |
| H11356104 | BG | Bunge | $6.5M | 2.01% | 80,000 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $6.0M | 1.85% | 100,000 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $4.6M | 1.42% | 279,308 | Common | SOLE |
| 925815102 | VICR | Vicor | $4.5M | 1.39% | 90,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $4.2M | 1.31% | 73,900 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $4.0M | 1.25% | 131,000 | Common | SOLE |
| 163851108 | CC | Chemours | $4.0M | 1.23% | 250,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $3.9M | 1.22% | 82,105 | Common | SOLE |
| N53745100 | LYB | Lyondellbasell | $2.9M | 0.91% | 60,000 | Common | SOLE |
| 749607107 | RLI | RLI | $2.7M | 0.82% | 40,800 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $1.6M | 0.51% | 253,000 | Common | SOLE |
| 532457108 | LLY | Eli Lilly | $1.5M | 0.47% | 2,000 | Common | SOLE |
| 92333F101 | VG | Venture Global | $1.4M | 0.44% | 100,000 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $1.3M | 0.40% | 55,784 | Common | SOLE |
| 91911K102 | — | Bausch Health | $1.1M | 0.34% | 171,000 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $1.0M | 0.32% | 195,073 | Common | SOLE |
| 268311107 | EDAP | EDAP | $1.0M | 0.31% | 438,652 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $918,777 | 0.28% | 729,188 | Common | SOLE |
| 044209104 | — | Ashland | $718,650 | 0.22% | 15,000 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $598,185 | 0.19% | 68,286 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences | $582,500 | 0.18% | 250,000 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $576,962 | 0.18% | 58,279 | Common | SOLE |
| 92939U106 | WEC | WEC Energy | $452,058 | 0.14% | 3,945 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.